Viewing Study NCT01192295


Ignite Creation Date: 2025-12-24 @ 1:20 PM
Ignite Modification Date: 2025-12-29 @ 12:35 PM
Study NCT ID: NCT01192295
Status: COMPLETED
Last Update Posted: 2020-03-23
First Post: 2010-08-30
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids
Sponsor: Purdue Pharma LP
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2010-11
Start Date Type: None
Primary Completion Date: 2014-07
Primary Completion Date Type: ACTUAL
Completion Date: 2014-07
Completion Date Type: ACTUAL
First Submit Date: 2010-08-30
First Submit QC Date: None
Study First Post Date: 2010-09-01
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2015-01-22
Results First Submit QC Date: None
Results First Post Date: 2015-02-06
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2020-03-19
Last Update Post Date: 2020-03-23
Last Update Post Date Type: ACTUAL